TET1 and metabolic disease: Although the present study has some limitations, such as a limited number of clinical samples and the unknown specific binding sites between TET1 and HDAC1, it expands our understanding of the biological function of TET1 in metabolic diseases and provides a new perspective to reveal the pathogenesis of hyperthyroidism.